Matinas BioPharma Holdings, Inc. (MTNB): Total Liabilities
$2.38M
As of 2025-12-31
$1.61M
As of 2026-06-30
-33.8%
3-year compound annual growth
-20.0%
5-year compound annual growth
+0.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.38M | -52.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $5.05M | -13.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.86M | -28.4% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $8.18M | -7.4% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $8.83M | +22.0% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $7.24M | +0.7% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $7.19M | +89.1% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $3.80M | +1.6% | 2020-03-09, Balance as of period end |
| 2017-12-31 | $3.74M | +40.3% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $2.67M | +14.3% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $2.33M | +105.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $1.13M | +32.0% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $859.0K | n/a | 2015-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $2.38M | -52.9% |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $1.43M | +109.7% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $37.17M | +21.3% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.57M | +106.0% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $5.49M | -10.4% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $11.38M | +12.4% |
| OS Therapies Inc (OSTX) | 2025-12-31 | $11.86M | +151.0% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $1.45M | +74.2% |
Compare MTNB, TELO, CPMD, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗